Abstract
Between 1981–1999, 75 patients treated for supraglottic SCC with horizontal supraglottic laryngectomy (HSL) at the Otolaryngology Head and Neck Surgery Department of Lausanne University Hospital were retrospectively studied. There were 16 patients with T1, 46 with T2 and 13 with T3 tumors. Among these, 16 patients (21%) had clinical neck disease corresponding to stage I, II, III and IV in 12, 39, 18 and 6 patients, respectively. All patients had HSL. Most patients had either elective or therapeutic bilateral level II–IV selective neck dissection. Six patients (8%) with advanced neck disease had ipsilateral radical and controlateral elective II–IV selective neck dissections. Adjuvant radiotherapy was given to 25 patients (30%) for either positive surgical margins (n=8), pathological nodal status (n=14) or both (n=3). Median follow-up was 48 months (range, 24–199). Five-year disease-specific survival and locoregional and local control were 92, 90 and 92.5%, respectively. Among five patients who were diagnosed with local recurrence, one had a total laryngectomy (1.4%); the others were treated by endoscopic laser surgery. Two patients had both a local and regional recurrence. They were salvaged with combined surgery and radiotherapy, but eventually died of their disease. Cartilage infiltration seems to influence both local control (P=0.03) and disease-specific survival (P=0.06). There was a trend for worse survival with pathological node involvement (P=0.15) and extralaryngeal extension of the cancer (P=0.1). All patients except one recovered a close to normal function after the treatment. Aspiration was present in 16 patients (26%) in the early postoperative period. A median of 16 days (7–9) was necessary to recover a close to normal diet. Decannulation took a median of 17 days (8–93). Seven patients kept a tracheotomy tube for up to 3 months because of persistent aspiration. There was no permanent tracheostomy or total laryngectomy for functional purposes. Horizontal supraglottic laryngectomy remains an adequate therapeutic alternative for supraglottic squamous cell carcinoma, offering an excellent oncological outcome. The postoperative functional morbidity is substantial, indicating the need for careful patient selection, but good laryngeal function recovery is the rule. The surgical alternative is endoscopic laser surgery, which may offer comparable oncological results with less functional morbidity. Nevertheless, these two different techniques need to be compared prospectively.
Similar content being viewed by others
References
DeSanto LW (1985) Cancer of the supraglottic larynx: a review of 260 patients. Otolaryngol Head Neck Surg 93:705–711
Spaulding CA, Hahn SS, Constable WC (1987) The effectiveness of treatment of lymph nodes in cancers of the pyriform sinus and subglottis. Int J Radiat Oncol Biol Phys 13:963–968
Alonso JM (1947) Conservative surgery of cancers of the larynx. Trans Am Acad Ophtalmol Otolaryngol 51:633–642
Bocca E (1991) Surgical management of supraglottic cancer and its lymph nodes metastases in a conservative perspective. Ann Otol Rhinol Laryngol 100:261–267
DeSanto LW (1990) Early supraglottic cancer. Ann Otol Rhinol Laryngol 99:593–597
Levendag P, Vikram B (1987) The problem of neck relapse in early stage supraglottic cancer—results of different treatment modalities for the clinically negative neck. Int J Radiat Oncol Biol Phys 13:1621–1624
Mendenhall WM, Pearsons JT, Mancuso AA (1996) Radiotherapy for squamous cell carcinoma of the larynx: an alternative to surgery. Head Neck 18:24–35
Bron L, Brossard E, Monnier P, Pasche P (2000) Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope 110:627–634
Bron LP, Pasche P, Monnier P, Schweizer V (2002) Functional analysis after supracricoid partial laryngectomy with CHEP or CHP. Laryngoscope 112:1289–1293
Bron LP, Soldati D, Zouhair A, Ozsahin M, Brossard E, Monnier P, Pasche P (2001) Treatment of early stage squamous cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck 23:823–829
Ambrosch P, Kron M, Steiner W (1998) Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107:680–688
Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W (1998) Transoral laser surgery for supraglottic cancer. Arch Otolaryngol Head Neck Surg 124:1245–1250
Rudert HH, Werner JA, Höft S (1999) Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 108:819–827
Lee NK, Goepfert H, Wendt CD (1990) Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson cancer center experience with combined therapy. Laryngoscope 100:831–836
Lutz CK, Johnston JT, Wagner RL, Myers EN (1990) Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhinol Laryngol 99:12–17
Nicolai P, Redalli LO, Tomenzoli D, Barezzani MG, Bertoni F, Bignardi M, Antonelli AR (1997) Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck:323–334
Freeman DE, Mancuso AA, Parsons JT, Mendenhall WM, Million RR (1990) Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results. Int J Radiat Oncol Biol Phys 19:485–490
Spaulding CA, Krochak RJ, Hahn SS, Constable WC (1986) Radiotherapeutic management of cancer of the supraglottis. Cancer 57:1292–1298
Mendenhall WM, Parsons JT, Stringer SP, Cassissi NJ (1997) Radiotherapy for carcinoma of the supraglottis. Otolaryngol Clinics North Am 30:145–161
Spaulding CA, Constable WC, Levine PA, Cantrell RW (1989) Partial laryngectomy and radiotherapy for supraglottic cancer: a conservative approach. Ann Otol Rhinol Laryngol 98:125–129
Grosjean P, Pasche P, Monnier P (2000) Die Frühdiagnosevon Karzinomen im Kopf- und Halsbereich. Interventionelle und diagnostische Bronchologie. Herausgegeben K. Wassermann. München-Deisenhofen. Dustri-Verlag
Licciardello JT, Spitz MR, Hong MPH, Hong WK (1989) Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, oesophagus and lung. Int J Radiat Oncol Biol Phys 17:467–476
Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G (1997) Supraacricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol 18:385–390
Bocca E, Pignataro O, Oldini C (1983) Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol 92:14–18
Spriano G, Antognoni P, Sanguinetti G, Sormani M, Richetti A, Ameli F, Piantanida R, Luraghi R, Magli A, Corvo R, Tordiglione M, Vitale V (2000) Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy. Am J Otolaryngol 21:14–21
Steiniger JR, Parnes SM, Gardner GM (1997) Morbidity of combined therapy for the treatment of supraglottic carcinoma: supraglottic laryngectomy and radiotherapy. Ann Otol Rhinol Laryngol 106:151–158
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was presented at the 2nd World Congress of the International Federation of Head and Neck Oncologic Societies, Rio de Janeiro, Brazil, 29 November–2 December 2002.
Rights and permissions
About this article
Cite this article
Bron, L.P., Soldati, D., Monod, ML. et al. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma. Eur Arch Otorhinolaryngol 262, 302–306 (2005). https://doi.org/10.1007/s00405-004-0824-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-004-0824-y